Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00100 |
| Species: | Homo sapiens |
| Position : | chr8:54268120-54269407 |
| Year: | 2023 |
| Title: | Dynamic network-guided CRISPRi screen identifies CTCF-loop-constrained nonlinear enhancer gene regulatory activity during cell state transitions |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 37488417 |
| MONDO: | |
| Tissue: | Definitive endoderm |
| Tissue Ontology ID: | UBERON:0005425 |
| Cell Source: | HUES8 |
| CVCL ID: | CVCL_B207 |
| Cell Type: | human embryonic stem cell |
| Cell Ontology ID: | CL:0000335 |
| Experiment Type: | dCas9-KRAB CRISPRi loss-of-function, Hi-C chromatin contact validation |
| High Throughput Method: | ATAC-seq, H3K27ac ChIP-seq, RNA-seq, scRNA-seq, pooled CRISPRi screening |
| Low Throughput Method: | RT-qPCR, FACS flow cytometry, lentiviral transduction |
| Target gene : | SOX17 |
| TF name : | SOX17 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| SOX17 | Deactivation of the beta-catenin transactivating complex | reactome | 42 |
| SOX17 | Wnt signaling pathway | kegg | 135 |
| SOX17 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01893 | chr8:54268115-54268740 | Cerebellum | medulloblastoma cell | medulloblastoma |